A dose-finding and safety phase I trial of Fraunhofer CMB's plant-derived influenza H5N1 vaccine in healthy volunteers.

Trial Profile

A dose-finding and safety phase I trial of Fraunhofer CMB's plant-derived influenza H5N1 vaccine in healthy volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Dec 2010

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary)
  • Indications Influenza A virus infections
  • Focus Adverse reactions
  • Sponsors Fraunhofer USA Center for Molecular Biotechnology
  • Most Recent Events

    • 10 Dec 2010 New trial record
    • 07 Dec 2010 This trial has been initiated, according to a Fraunhofer USA CMB media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top